SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-000755
Filing Date
2020-03-16
Accepted
2020-03-16 16:10:15
Documents
1
Period of Report
2020-03-15

Document Format Files

Seq Description Document Type Size
1 form4-03162020_040301.html 4  
1 form4-03162020_040301.xml 4 7708
  Complete submission text file 0001415889-20-000755.txt   9344
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107
Business Address
WEAVER GREGORY L (Reporting) CIK: 0001251779 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 20717228